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Summary
Cyclin-dependent kinases (CDKs) play crucial roles in
promoting DNA replication and preventing rereplication in
eukaryotic cells [1–4]. In budding yeast, CDKs promote
DNA replication by phosphorylating two proteins, Sld2 and
Sld3, which generates binding sites for pairs of BRCT
repeats (breast cancer gene 1 [BRCA1] C terminal repeats)
in the Dpb11 protein [5, 6]. The Sld3-Dpb11-Sld2 complex
generated by CDK phosphorylation is required for the
assembly and activation of the Cdc45-Mcm2-7-GINS (CMG)
replicative helicase. In response to DNA replication stress,
the interaction between Sld3 and Dpb11 is blocked by the
checkpoint kinaseRad53 [7],whichprevents late origin firing
[7, 8]. Here we show that the two key CDK sites in Sld3 are
conserved in the human Sld3-related protein Treslin/ticrr
and are essential for DNA replication. Moreover, phosphory-
lation of these two sitesmediates interaction with the orthol-
ogous pair of BRCT repeats in the human Dpb11 ortholog,
TopBP1. Finally, we show that DNA replication stress
prevents the interaction between Treslin/ticrr and TopBP1
via the Chk1 checkpoint kinase. Our results indicate that
Treslin/ticrr is a genuine ortholog of Sld3 and that the Sld3-
Dpb11 interaction has remained a critical nexus of S phase
regulation through eukaryotic evolution.
Results and Discussion
CDK-Dependent Interaction between Treslin/Ticrr and
TopBP1
Eukaryotic DNA replication initiates from multiple replication
origins, which each fire just once per cell cycle. To achieve
this, the Mcm2-7 helicase is loaded around double-stranded
DNA during G1 phase as an inactive double hexamer [1].
This loading reaction is inhibited by CDK and, therefore, can
only occur during G1 phase when CDK activity is low. The heli-
case is then activated during S phase by formation of the CMG
complex, which requires a set of loading factors including
Sld2, Sld3, and Dpb11. In budding yeast, this step is promoted
by CDK phosphorylation of Sld2 and Sld3. This dual role for
CDK ensures that replication origin firing is limited to once
per cell cycle [2].*Correspondence: john.diffley@cancer.org.ukWe were interested in understanding how CDK regu-
lates initiation in mammalian cells and began by identifying
binding partners of the breast cancer gene 1 (BRCA1) C ter-
minus (BRCT) repeats in the mammalian ortholog of Dpb11,
TopBP1. We found a fragment of a human open reading
frame (C15orf42), subsequently identified as Treslin and ticrr
[9, 10], in a two-hybrid screen for TopBP1-interacting pro-
teins. Analysis of the Treslin/ticrr sequence identified a
domain conserved across eukaryotic species, the Sld3-Tre-
slin/ticrr domain (STD) [11]. Although the Treslin/ticrr protein
is large (1910 aa), the TopBP1-interacting fragment con-
tained amino acid residues 790–1172, which lie downstream
of the STD, similar to the position of the essential CDK sites
relative to the STD in budding yeast Sld3 (Figure 1A). Fig-
ure 1B shows that this two-hybrid interaction (growth on –His
plates) occurs with a construct containing BRCT repeats 0–5
of TopBP1 as well as a construct containing BRCT0–3. In
yeast, CDK phosphorylation of Sld3 generates a binding
site for the tandem BRCT repeats 1 and 2 in Dpb11.
BRCT1 and 2 of TopBP1 that are contained in the BRCT0–3
construct are orthologous [12] to Dpb11’s BRCTs 1 and 2
and are essential for replication [10], suggesting that
BRCT1/2-mediated CDK-dependent Sld3 binding could be
conserved. Consistent with this hypothesis, GST-TopBP1-
BRCT0/1/2 could bind full-length Treslin/ticrr from cell
lysates (Figure 1C). Lambda phosphatase treatment of the
extract, which caused Treslin/ticrr to migrate slightly faster
in sodium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS-PAGE), eliminated interaction with TopBP1 (Figure 1C,
lanes 1 and 2). Phosphorylation of extract proteins with re-
combinant cyclinA/Cdk2 caused Treslin/ticrr to migrate
more slowly in SDS-PAGE and greatly enhanced interaction
with TopBP1 (lanes 3 and 4) (note that interaction with Tre-
slin/ticrr is not evident in lane 3 because of the short ex-
posure time compared to lane 1). This series of experi-
ments suggests a CDK-dependent interaction of Treslin with
TopBP1 via BRCT0/1/2. To examine interactions between
full-length proteins, we immunoprecipitated TopBP1 from
stable cell lines expressing Treslin/ticrr. Figure 1D shows
that the anti-TopBP1 antibody did not coimmunoprecipitate
Treslin/ticrr from lambda phosphatase-treated extracts but
did coimmunoprecipitate Treslin/ticrr after treating extracts
with CDK. BRCT0/1/2 of TopBP1 has previously been shown
to bind the 9-1-1 complex component Rad9 when phosphor-
ylated at S387 [13]. A phosphorylated synthetic peptide
derived from Rad9 (pRad9) was able to bind TopBP1-
BRCT0/1/2 and to elute full-length Rad9 from a complex
with TopBP1-BRCT0/1/2 (see Figure S1 available online).
Figure 1D shows that the phosphorylated Rad9 peptide,
but not an unphosphorylated control (Rad9), also eluted Tre-
slin from its complex with TopBP1.
The CDK-dependent interaction was reconstituted with
purified cyclinA/Cdk2, GST-TopBP1(0/1/2), and a fragment
of Treslin/ticrr containing amino acid residues 790–1172 gen-
erated in reticulocyte lysate by in vitro translation (Figure 1E).
Figure 1E also shows that a fragment comprising amino acid
residues 790–1056 but not 1014–1172 interacted with TopBP1
in a CDK-dependent manner.
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Figure 1. CDK-Induced Interaction of Treslin/Ticrr with TopBP1-BRCT0/1/2 Is Dependent on Treslin Phosphorylation between Amino Acids 790 and 1056
(A) Schematic indicating conservation between human and putative Arabidopis thaliana Treslin/ticrr as well as yeast Sld3. All three proteins share an Sld3/
Treslin domain (STD) [11]. A region conserved in Treslins (CIT) is only present in metazoans. pT600/pS622 indicates that Dpb11-binding Sld3 cyclin-depen-
dent kinase (CDK) sites are situated C-terminal of the STD. Forty-six potential CDK sites (S/T-P motifs) conserved between human and mouse Treslins are
shown. Fragments of Treslin C-terminal of the STD: amino acids 790–1172 (used in [B], [E], and Figure 2B), 790–1056, and 1014–1172 (both 1E).
(B) Treslin-790–1172 interacts with TopBP1-BRCT0–3 in yeast two-hybrid analysis. For this yeast two-hybrid analysis, amino-terminally LexA-tagged
TopBP1-1–549 (BRCT0–3) or 1–766 (BRCT0–5) and amino-terminally Gal4-tagged Treslin-790-1172 were used. pB27 and pB6 served as empty vector
controls.
(C) Interaction of full-length Treslin/ticrr with TopBP1-BRCT0/1/2 is reduced by phosphatase and enhanced by Cdk2 treatment. AcGFP-Flag-Treslin was
pulled down from lysates of transiently transfected HEK293T cells using GST-TopBP1-BRCT0/1/2 (amino acids 1–360) immobilized on glutathione sephar-
ose. The following abbreviations are used: l, lambda phosphatase; CDK, cyclinA/Cdk2; 0/1/2, GST-TopBP1-BRCT0/1/2 (amino acids 1–360); Treslin immu-
noblot: anti-GFP; exp., exposure; Coom., Coomassie staining.
(D) Phosphorylation-dependent interaction between Treslin/ticrr and endogenous full-length TopBP1 is mediated by TopBP1-BRCT0/1/2. A competition of
binding experiment using Rad9 peptides and coimmunoprecipitates of Treslin-wild-type (WT) with endogenous TopBP1 is shown. Stable HeLa-Kyoto cells
expressing AcGFP-Flag-Treslin were used. The following abbreviations are used: IP, immunoprecipitation; Pep, peptide; Rad9/pRad9, nonphospho/phos-
pho-S387-Rad9 peptides; CDK, cyclinA/Cdk2; l, lambda phosphatase; immunoblots: Treslin, anti-GFP; TopBP1, anti-TopBP1.
(E) CDK phosphorylation sites of Treslin/ticrr required for association with TopBP1-BRCT0/1/2 are situated between amino acids 790 and 1056. In vitro-
translated Treslin fragments containing the indicated amino acids were pulled down using TopBP1-BRCT0/1/2 in the presence or absence of exogenous
Cdk2. The following abbreviations are used: CDK, cyclinA/Cdk2 BRCT0/1/2, GST-TopBP1-BRCT0/1/2 (amino acids 1–360); Treslin fragments: amino acids
790–1172, 790–1056, and 1014–1172, respectively; Inp, input; autoradiography, detection of 35S-Met-labeled in vitro-translated Treslin.
See also Figure S1.
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Interaction
In parallel with these interaction studies, we sought to identify
CDK phosphorylation sites equivalent to Sld3 T600 and S622,
which have been conserved in Sld3/Treslin/ticrr family
members. Out of 70 potential CDK sites in human Treslin/ticrr
(46 sites conserved between humans and mouse; Figure 1A),
we found two sites, T969 and S1001, which were each
embedded in short sequencemotifs that are conserved among
family members (Figure 2A). These sites are contained within
the smallest fragment shown to interact with TopBP1 in Fig-
ure 1E. We next tested the relative importance of these two
phosphorylation sites. Figure 2B shows that mutation of T969
to alanine in the context of the in vitro-translated Treslin frag-
ment eliminated CDK-induced association with TopBP1-
BRCT0/1/2 whereas the S1001-to-alanine mutation resulted in
a significant reduction in interaction efficiency. The migration
of wild-type and mutant Treslin/ticrr fragments in SDS-PAGEwere reduced upon CDK treatment to a similar extent, indi-
cating that phosphorylation of CDK sites outside T969 and
S1001 (there are 11 potential CDK sites on the fragment) can
occur and contribute to the reduced migration of TopBP1.
These phosphorylations, however, do not promote efficient
TopBP1binding, providing an internal control for the specificity
of the interaction. To analyze further the sequence require-
ments for this interaction, we examined the ability of TopBP1
to bind biotinylated synthetic peptides. Figure 2C shows that
recombinant TopBP1 (0/1/2) could be pulled down with a Tre-
slin/ticrr peptide containing sequences around T969 when
T969 was phosphorylated, but not when T969 was unphos-
phorylated, showing that phosphorylation of T969, rather than
the threonine residue itself, is critical for the interaction. More-
over, mutation of conserved residues at position21 or23 rela-
tive to T969 (see Figure 2A, asterisks) eliminated TopBP1
binding (Figure 2C). Similarly, TopBP1 (0/1/2) bound to a Tre-
slin/ticrr peptide containing sequences around S1001 when
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Figure 2. Phosphorylation of Treslin/Ticrr-T969 and S1001 Creates an Interaction Surface for TopBP1-BRCT0/1/2
(A) Treslin-T969 and S1001 align with Sld3-T600 and S622. A protein computational sequence analysis of TP/SP phosphorylation motifs [30] for the Treslin/
Sld3 family is shown. The alignment was represented using the program Belvu and a color scheme indicating the average BLOSUM62 scores (which are
correlated with amino acid conservation) of each alignment column. Red represents average BLOSUM62 scores greater than 3, violet between 3 and 1,
and light yellow between 1 and 0.2. Asterisks indicate amino acids mutated for (C).
(B) T969 and S1001 are required for CDK-mediated association of Treslin-790–1172 with TopBP1-BRCT0/1/2. In vitro-translated Treslin-790–1172
fragments were pulled down using immobilized GST-TopBP1-BRCT0/1/2 in the presence or absence of exogenous Cdk2. See Figure 1E for legend, except
mutant Treslin fragments 969A and 1001A, T969, or S1001 mutated to alanine.
(C) Phosphorylation of Treslin-T969 and S1001 creates interaction surfaces for TopBP1-BRCT0/1/2. Recombinant TopBP1-BRCT0/1/2 was pulled down
using immobilized biotinylated Treslin peptides. 0/1/2, GST-TopBP1-BRCT0/1/2 (amino acids 1–360); biotinylated peptides: pT969, pS1001, phospho-
Treslin-T969, S1001; 21K, 23F, 21A, 22A, 23D, 24D: point mutation of amino acids indicated by asterisks in (A); Coom., Coomassie staining; nonphos-
pho-S1001-peptide was generated by lambda phosphatase treatment of pS1001.
(D) Functional TopBP1-BRCT1 and 2 and double phosphorylation of Treslin/ticrr at T969 and S1001 are required for maximal TopBP1-Treslin interaction. A
fluorescence polarization analysis using Treslin peptides and TopBP1-BRCT0/1/2 is shown. The following abbreviations are used: dissociation constants in
parentheses; TopBP1-BRCT0/1/2 versions (amino acids 1–290): WT, wild-type; B1/2mut, BRCT1 and 2 inactivated (K155E/K250E); B1mut, BRCT1 inacti-
vated (K155E); B2mut, BRCT2 inactivated (K250E). FITC-Treslin peptides: pT969, pS1001, 23PO4, phospho-Treslin-T969, S1001, T969/S1001.
(E) Treslin/ticrr interacts with endogenous TopBP1 dependent on T969 and S1001. Interaction of Treslin-WT and 2PM with endogenous TopBP1 was
analyzed by coimmunoprecipitation. The following abbreviations are used: WT and 2PM, HeLa-Kyoto cells stably expressing Ac-GFP-Treslin-wild-type
or T969A/S1001A; IP, immunoprecipitation; immunoblots: Treslin, anti-GFP; TopBP1, anti-TopBP1.
See also Figure S2.
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1154S1001 was phosphorylated, but not when it was unphosphory-
lated. Mutation of conserved residues at 21, 23, and 24 rela-
tive to S1001 eliminated binding whereas mutation of the 22
residue reduced binding. We next used fluorescence polariza-
tion as a more quantitative approach to measure the affinity of
TopBP1 for thesepeptides.Figure2D (toppanel) shows that the
doubly phosphorylated peptide (23PO4) has a higher affinity
for TopBP1 (0/1/2) than either singly phosphorylated peptide
as the lower Kd values (in parentheses) indicate. The pT969
peptide had a higher affinity than the pS1001 peptide, consis-
tent with results in Figure 2B. To examine the roles of the indi-
vidual BRCT repeats in binding, we used mutants containing
single point mutations in the putative phosphopeptide binding
site inBRCT1 (B1mut) orBRCT2 (B2mut) or both (B1/2mut) [14].
Figure 2D (top panel) shows that mutation of both BRCTs abol-
ishes binding of the 23PO4 peptide, confirming a canonical
phosphorylation-dependent BRCT-phosphopeptide bindingevent. Mutating BRCT1 alone affected pT969 binding more
than mutation of BRCT2 (middle panel), whereas inactivation
of BRCT2 had a bigger effect on pS1001 binding thanmutation
of BRCT1 (bottom panel). These results suggest that pT969
interacts primarily with BRCT1 whereas pS1001 interacts
primarily with BRCT2. We note, however, that neither peptide
appears to interact exclusively with one or the other BRCT
repeat, consistent with the similarity in the primary amino acid
sequence surrounding the two critical CDK sites (Figures 2A
and 2C). Finally, we tested the importance of these phosphory-
lation sites in the context of the full-length Treslin/ticrr protein.
Figure 2E shows that a double alanine substitution of these two
phosphorylated residues (T969 andS1001) in the context of the
full-length Treslin/ticrr completely prevented interaction with
endogenous TopBP1 (as well as with recombinant TopBP1-
BRCT0/1/2; Figure S2A). Thus, these two CDK sites are essen-
tial for interaction with TopBP1.
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Figure 3. Treslin/Ticrr-T969 and S1001 Are Required for Replication
(A) Specific knockdown of Treslin/ticrr by RNA interference (RNAi). Relative Treslin amounts in HeLa-Kyoto cells treated for 48 hr or 72 hr with small inter-
fering RNA (siRNA) against Treslin (siTr) or GL2 (siCtr) were analyzed by immunoblotting. Antibodies: Treslin, anti-Treslin; loading, anti-MCM4.
(B) Knockdown of Treslin/ticrr results in accumulation of slowly replicating cells in S phase. Cell-cycle distribution and BrdU incorporation of HeLa-Kyoto
cells treated for 48 hr with siRNA against Treslin (siTr) or GL2 (siCtr) were analyzed by flow cytometry. Colored bars indicate fractions of cells in respective
cell-cycle phase. The number above the black line in dot plots indicates cells incorporating BrdU more efficiently than the vast majority of siTr-cells. The
following abbreviations are used: PI, propidium iodide; BrdU, 5-bromo-20-deoxyuridine; log, logarithmic scale; 2N/4N, DNA content.
(C) RNAimediated knockdown of endogenous Treslin/ticrr but not siRNA-resistant transgenes using stable cell lines expressing Treslin-WT or 2PM. Relative
Treslin amounts in control cells and cell lines stably expressing Ac-Flag-GFP-Treslin-WT (wild-type) or 2PM (T969A/S1001A) treated with Treslin (siTr) or
control siRNA (siCtr) as in Figure 3B were analyzed by immunoblotting using anti-Treslin antibodies and Ponceau staining (Pon.).
(D) Expression of Treslin/ticrr-WT but not of 2PM rescues RNAi knockdown phenotype of endogenous Treslin/ticrr. Control cells and cell lines stably ex-
pressing Treslin-WT or 2PM treated with Treslin or control siRNA were analyzed as in (B). See (B) and (C) for legend.
See also Figure S3.
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To test the importance of these sites for Treslin function, we
developed a small interfering RNA (siRNA) strategy to reduce
the levels of endogenous Treslin/ticrr but not siRNA-resistant
transgenes. The immunoblot in Figure 3A shows that we could
effectively reduce endogenous Treslin/ticrr protein levels by
siRNA. Flow cytometry analysis demonstrated that this knock-
down (siTr) resulted in almost complete loss of cells capable of
incorporating bromodeoxyuridine (BrdU) (Figure 3B, top row,
middle panel) relative to a control siRNA (siCtr; top row, left
panel) and also caused a dramatic accumulation of S phase
cells (Figure 3B, bottom panel). Quantification of cells in
different cell-cycle stages revealed that Treslin/ticrr-RNAi cells
accumulate primarily in S phase (upper panel, colored bars),
consistent with an inhibition of DNA replication and similar to
previously published results [9, 10]. We next used stable
HeLa-Kyoto cell lines expressing siRNA-resistant transgenes
encoding either wild-type (WT) Treslin/ticrr or the double point
mutation (2PM),which cannot interactwith TopBP1 (Figure 2E).
Figure 3C shows that both proteins are expressed to similarlevels and are resistant to siRNA treatment, in contrast to
endogenous Treslin in control cells. Figure 3D shows that
expression of the wild-type Treslin/ticrr restored significant
BrdU incorporation (dot plots, middle panel) and also greatly
reduced the number of cells in S phase (histograms, bottom
panel and colored bars) in cells treated with siRNA against Tre-
slin/ticrr. However, the double point mutant did not restore
either BrdU incorporation or normal cell-cycle distribution (for
more cell lines, see Figure S3). The inability of this double
alanine substitution mutant to support DNA replication shows
that T969 and S1001 are essential for Treslin/ticrr function.
This supports the idea that phosphorylation of these residues
by CDK is essential to generate a binding site for TopBP1,
although we cannot rule out the possibility that the mutations
affect some other function of Treslin/ticrr. Additionally, our
results do not address the possible function of the remaining
68 CDK sites in Treslin/ticrr. We note that the 2PM mutant
migrates very similarly to wild-type protein in SDS-PAGE and
migrates faster after lambda phosphatase treatment (Fig-
ure S2A), indicating that at least some of these remaining CDK
BA
Figure 4. Activation of the Replication Checkpoint Prevents Association of Treslin/Ticrr with TopBP1-BRCT0/1/2
(A) Stalling replication forks with hydroxyurea (HU) reduces the amount of phosphorylated Treslin/ticrr and prevents association with TopBP1-0/1/2 depen-
dently on Chk1. Treslin was pulled down with immobilized TopBP1-BRCT0/1/2 from lysates of untreated cells or cells treated for 2 hr with hydroxyurea (HU)
in the presence or absence of Chk1 inhibitor. Note that nonphospho- and phospho-Treslin (marked with asterisks) are only discernible by electrophoresis
using 3%–8% Tris acetate gels (Bio-Rad) used for this figure. Stably AcGFP-Flag-Treslin-expressing HeLa-Kyoto lines were used. The following abbrevi-
ations are used: Inh: Chk1 inhibitor AZD7762; Pon., Ponceau staining immunoblot: Treslin, anti-GFP.
(B) Conservation of Sld3 function and regulation in budding yeast and metazoans. In yeast and metazoans, Sld3 mediates CDK-dependent origin firing.
Activation of the intra-S phase checkpoint prevents this process. Note that this checkpoint-dependent inhibition is functionally but possibly not mechanis-
tically conserved (see Conclusions). The following abbreviations are used: APC/C, anaphase-promoting complex/cyclosome; S cyclin/CDK, cyclin/CDK
complexes driving S phase; pre-RC, prereplicative complex.
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1156sites may be phosphorylated in vivo. However, even if these
remaining sites are phosphorylated, they cannot promote
TopBP1 binding in the absence of T969/S1001 (Figure 2E).
Treslin/Ticrr-TopBP1 Interaction Is Inhibited by Chk1
Lastly, we examined Treslin/ticrr and its interaction with
TopBP1 after replicative stress. Budding yeast Sld3 is hyper-
phosphorylated in a Rad53-dependent manner after treatment
of cells with hydroxyurea (HU), and this hyperphosphorylation
blocks its ability to interact with Dpb11 [7, 8]. As shown in Fig-
ure 4A, Treslin does not appear to become hyperphosphory-
lated after 2 hr treatment with HU. Instead, it migrates faster
after HU treatment, similar to the migration of Treslin/ticrr after
treatment with lambda phosphatase. However, similar to the
situation in budding yeast, Figure 4A shows that the ability of
TopBP1-BRCT0/1/2 to interact with Treslin/ticrr is greatly
reducedafterHU treatment. Todeterminewhether this reduced
interaction is dependent upon checkpoints, wepretreated cells
with the Chk1 inhibitor AZD7762 30 min before addition of HU
treatment. Figure 4A shows that Chk1 inhibition prevents the
apparenthypophosphorylationofTreslin/ticrr andalso restores
its ability to interact with TopBP1. Taken together, these exper-
iments indicate that the DNA damage checkpoint, via Chk1,
inhibits the interaction between TopBP1 and Treslin/ticrr.
In addition to its role in promoting replication, CDK inhibits
loading of Mcm2-7 into prereplicative complexes (pre-RCs)
by directly phosphorylating and inhibiting multiple pre-RC
components. However, mutational inactivation of individual
CDK phosphorylation sites in budding yeast pre-RC compo-
nents including ORC, Cdc6, and Mcm2-7 has little or no effect
on cell viability or the block to rereplication. Significant levels
of rereplication and loss of viability are only seen when CDK
regulation of multiple pre-RC components is eliminated [15].
This high degree of redundancy is probably important for the
robustness of the block to rereplication [2] but also contributes
to the rapid evolution of licensing regulation by CDKs [16]. As
a consequence, specific CDK phosphorylation sites involved
in this block to rereplication have not been conserved between
budding yeast and humans (discussed in [4, 16]). In contrast,
several individual CDK phosphorylation sites in budding yeast
Sld2 and Sld3 are either essential or extremely important forcell viability [5, 6, 17]. Consistent with this, our results show
that Sld3 phosphorylation sites have been conserved in
eukaryotic evolution.
Two lines of evidence suggest, however, that CDK phos-
phorylation of Sld2 may not be conserved in metazoans. First,
T84, the key CDK phosphorylation site in Sld2, is not present in
the apparent metazoan ortholog of Sld2, RecQL4 [18]. And
second, BRCT4 and 5 in TopBP1, which correspond to
BRCT3 and 4 in Dpb11 and are required for phosphopeptide
binding to Sld2 in yeast, are dispensable for initiating DNA
replication in Xenopus egg extracts [10]. The metazoan
TopBP1 has an additional single BRCT repeat (BRCT3)
inserted between the Sld3- and Sld2-interacting tandem pairs
in Dpb11 [12], which is essential for DNA replication in
Xenopus egg extracts [10]. Determining whether there are
additional CDK substrates required for initiating DNA replica-
tion in metazoans such as the recently discovered GEMC1
and DUE-B proteins [19, 20] and whether these proteins
interact with BRCT3 in TopBP1 will require further work.
The recent crystal structure of the N-terminal region of
TopBP1 [14] has confirmed that BRCT repeats 1 and 2 are quite
similar to each other and has revealed the presence of a phos-
phopeptide binding pocket in both repeats. Both Sld3 and
Treslin/ticrr contain two phosphorylation sites important for
binding. Sequences around the two phosphorylation sites in
Treslin/ticrr show significant similarity to each other: there is
a conserved acidic residue at position 21 and a conserved
hydrophobic residue at position 23, both of which are impor-
tant for TopBP1 binding to both sites (Figures 2A and 2C).
Indeed, both BRCT repeats appear able to bind to either phos-
phopeptide (Figure 2D), though there is a preference for BRCT1
to bind the T969peptide andBRCT2 to bind theS1001 peptide.
This suggests that the TopBP1-Treslin/ticrr interaction may
have evolved from a tandem duplication of both the BRCT
repeat in TopBP1 and the phosphopeptide binding site in
Treslin/ticrr. However, two phosphorylation sites are not an
absolute requirement for functional interaction with TopBP1
because the vertebrate and fission yeast 9-1-1 complex
component Rad9 requires just one phosphorylation site for
binding BRCT0/1/2 [13]. Moreover, the Arabidopsis thaliana
Treslin/ticrr homolog appears to contain just a single
Treslin/Ticrr Is an Essential CDK Substrate
1157conserved CDK site relative to the human and yeast proteins
(Figure S2B).
Budding yeast Sld3 becomes hyperphosphorylated in
response to DNA damage by the checkpoint kinase Rad53
[7, 8]. This phosphorylation blocks the interaction between
CDK-phosphorylated Sld3 and Dpb11 [7]. As we have shown
here, the interaction between Treslin/ticrr and TopBP1 is also
disrupted by the checkpoint pathway in human cells, in this
case by Chk1, which is responsible for the intra-S checkpoint
in mammalian cells [21]. However, in contrast to the situation
in budding yeast, the phosphorylation-dependent shift in SDS-
PAGE of Treslin/ticrr is reduced by the Chk1 kinase (Figure 4B),
suggesting thatChk1may either prevent the phosphorylation of
Treslin/ticrr by CDK or promote its dephosphorylation by an
unknown phosphatase. Whether this occurs by direct Chk1
phosphorylation of Treslin/ticrr or bydownregulation ofSphase
CDK activity, perhaps via Cdc25A destabilization [22, 23], is
unknown. Inbuddingyeast,CDKmust remainactive throughout
S phase to prevent the relicensing of origins that have fired.
Thus, the intra-S checkpoint cannot operate via CDK inactiva-
tion. The presence of CDK-independent mechanisms for pre-
venting rereplication in metazoans, such as the Cdt1 inhibitor,
geminin [24–26], and the Cdt1 degradation pathway [27–29],
which operates via a Cul4 ubiquitin ligase, allow the intra-S
checkpoint to inhibit CDK without inducing origin relicensing.
Taken together, our results indicate that Treslin/ticrr is a
bona fide ortholog of the yeast Sld3 protein and establishes
the Sld3-Dpb11 interaction as a critical point of S phase regu-
lation in eukaryotic cells (Figure 4B).
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